Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
3
×
cancer immunotherapy
3
×
life sciences
national
national blog main
novartis
bristol-myers squibb
samit hirawat
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
bill cassidy
biogen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
caelum biosciences
celgene
chuck grassley
corvus pharmaceuticals
crenezumab
deals
dengue fever
department of health and human services
detroit blog main
detroit top stories
dewpoint therapeutics
drug prices
eli lilly
genentech
What
year
3
×
acquisition
anniversary
approaches
bn
bristol
celgene
chief
clinical
company’s
corporation
diversity
hirawat
medical
myers
myers’s
officer
pipeline
progress
scrip
spoke
squibb
trial
alzheimer’s
bio
companies
different
drug
fail
gene
increases
latest
pharmaceutical
plan
prescription
price
prices
raise
roundup
start
Language
unset
Current search:
cancer
×
year
×
" cancer immunotherapy "
×
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
